Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Emily Carron"'
Autor:
Christophe Pedros, Emily Carron, Larissa Pikor, Barbara Sennino, Sowbarnika Ratliff, April Fraley, Justin Rahman, Niloufar Khojandi, Bryant Thompson, Mathew Thayer
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/e8ff8bd80b984ca0b04dd1886712491e
Autor:
Tom Lee, Mochtar Pribadi, Yijia Pan, Hui-Yi Chu, Bob Valamehr, Dan Lu, Philip Chu, Amit Mehta, Alec Witty, Eigen Peralta, Emily Carron, Lorraine Loter, Natalie Navarrete, Arvin Tam, Kenyon Lyon
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/95ab3c1a5515471cbfd0a78c80f97108
Publikováno v:
Mediators of Inflammation, Vol 2016 (2016)
Cancer stem cells (CSCs) are a unique subset of cells within tumors with stemlike properties that have been proposed to be key drivers of tumor initiation and progression. CSCs are functionally defined by their unlimited self-renewal capacity and the
Externí odkaz:
https://doaj.org/article/e95312ed9411440bb9c5bf2628079860
Autor:
Christophe Pedros, Larissa Pikor, Anna Fritzsche, Zachary K. Jilesen, Bethany Macleod, Niloufar Khojandi, Bryant Thompson, Matthew Thayer, Nikolas Bryan, Emily Carron, Sowbarnika S Ratliff, April Fraley, Jake Nikota, Robert Fisher, Sebastien Delpeut, Anna Kluew, Madysson Scott, Christian Laing, Leo He, Antoine Bernard, Nathalie Brassard, Simon Turcotte, Timothy J Langer, David Stojdl, Stewart Abbot, Barbara Sennino
Publikováno v:
Cancer Research. 83:4052-4052
Background: The autologous cell therapy field has investigated numerous novel strategies and processes to improve response rates and expand the use of adoptive cell therapies (ACT) to patient suffering from a broad range of cancers. Tumor infiltratin
Autor:
Eigen Peralta, Kenyon Lyon, Thomas H. Lee, Yijia Pan, Arvin Tam, Alec Witty, Mochtar Pribadi, Hui-yi Chu, Emily Carron, Natalie Navarrete, Bob Valamehr, Amit R. Mehta, Philip Chu, Dan Lu, Lorraine Loter
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundTransforming growth factor beta (TGFβ) is an immuno-suppressive cytokine present in the tumor microenvironment (TME) that creates considerable challenges for the treatment of solid tumors. Small molecule inhibitors targeting TGFβ exist, b
Autor:
Mark Landon, Anhco Nguyen, Eigen Peralta, Emily Carron, Helen Chu, Bahram Valamehr, Alec Witty, Shohreh Sikaroodi, Natalie Navarrete, Dan Lu, Thomas H. Lee
Publikováno v:
Cancer Research. 81:332-332
T cells require a combination of signals to properly activate and exhibit their full potential; signal 1 from the T cell receptor (TCR), signal 2 from costimulatory receptors and signal 3 from cytokine receptors can shape the function of T cells. Sec
Autor:
Joyee Yao, Thomas H. Lee, Dan Lu, Sandeep Kothapally Hanok, Daniel Shoemaker, Jason ORourke, Yinghui Sui, Natalie Navarrete, Matthew Denholtz, Bahram Valamehr, David J. Robbins, Eigen Peralta, Angela Gentile, Emily Carron, Cokey Nguyen, Eric Sung
Publikováno v:
Blood. 136:12-12
Despite the success of chimeric antigen receptor (CAR)-T cell therapy in various hematologic malignancies, obstacles to an effective therapeutic outcome are highly dependent on the tumor type being targeted and the immune microenvironment that the CA
Autor:
Bahram Valamehr, Samuel LaBarge, Yi-Shin Lai, Mochtar Pribadi, Suzanna Gasparian, Mandal Mili, Alma Gutierrez, Matthew Denholtz, Gloria Hsia, Jason ORourke, May Sumi, Bi-Huei Yang, Cokey Nguyen, Sandeep Kothapally Hanok, Alec Witty, Eric Sung, Amit R. Mehta, Raedun Clarke, Ramzey Abujarour, Eigen Peralta, Emily Carron, Thomas H. Lee, Emily Driver, Angela Gentile, Natalie Navarrete, David J. Robbins, Wen-I Yeh, Philip Chu, Chia-Wei Chang, Amanda D. Yzaguirre
Publikováno v:
Blood. 136:11-11
The development of chimeric antigen receptor (CAR) T cell therapeutics is widely recognized as a significant advancement for the treatment of cancer. However, several obstacles currently impede the broad use of CAR T cells, including the inherent pro
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
Mediators of Inflammation
Biblos-e Archivo. Repositorio Institucional de la UAM
Mediators of Inflammation, Vol 2016 (2016)
instname
Mediators of Inflammation
Biblos-e Archivo. Repositorio Institucional de la UAM
Mediators of Inflammation, Vol 2016 (2016)
Cancer stem cells (CSCs) are a unique subset of cells within tumors with stemlike properties that have been proposed to be key drivers of tumor initiation and progression. CSCs are functionally defined by their unlimited self-renewal capacity and the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e17d05d0f0fe174f8e90899afa0421cc
http://hdl.handle.net/10261/151193
http://hdl.handle.net/10261/151193
Publikováno v:
The FASEB Journal. 28
Most tumors have numerical and structural chromosome aberrations that can provide selective growth advantages. It has been reported that overexpression of DNA Polymerase B (Pol β) contributes to chromosome instability by inducing aneuplody, telomere